Metformin Ipca Laboratories Uk (Metformin Hydrochloride)

Metformin, a biguanide antidiabetic agent, is used to manage hyperglycemia in type 2 diabetes and related glucose‑handling disorders.

• Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
• Prediabetes (impaired glucose tolerance): delays progression to overt diabetes.
• Polycystic ovary syndrome (off‑label): assists in restoring ovulatory function and reducing insulin resistance.

• Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis, thereby decreasing hepatic glucose production. It also enhances peripheral insulin sensitivity, increasing glucose uptake in muscle and adipose tissue, and modestly reduces intestinal glucose absorption. The drug does not stimulate insulin secretion, which contributes to its low risk of hypoglycemia when used alone.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: frequent loose stools, especially during treatment initiation.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration in taste perception.
• Loss of appetite: reduced desire to eat.
• Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

• Lactic acidosis: rare but potentially fatal accumulation of lactate.
• Severe hypoglycemia: usually when combined with other glucose‑lowering agents.
• Vitamin B12 deficiency: long‑term therapy may impair absorption.
• Hepatic dysfunction: rare liver enzyme elevations.
• Skin rash or allergic reactions: occasional hypersensitivity.
• Peripheral neuropathy: very uncommon neurological symptoms.

Metformin requires careful patient assessment and monitoring.

• Renal impairment: avoid or adjust dose in patients with reduced kidney function.
• Hepatic disease: use with caution; monitor liver enzymes.
• Congestive heart failure: assess risk of lactic acidosis.
• Alcohol consumption: limit intake to reduce lactic acidosis risk.
• Elderly patients: start with lower dose and monitor tolerance.
• Store below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk.
• Cimetidine: may raise metformin plasma concentrations.
• Alcohol: potentiates lactic acidosis.
• Digoxin: concurrent use may increase risk of hypoglycemia.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• Diuretics (thiazides): can affect renal clearance of metformin.
• ACE inhibitors/ARBs: monitor renal function when combined.
• Sulfonylureas: increased risk of hypoglycemia.
• Thyroid hormones: may require dose adjustments.